← Open Payments lookup

REBECCA LANDRY: Open Payments

NPI 1316537525 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,099 in 95 payments from 15 companies in 2025. Trend: 2023 $1,676 · 2024 $1,567 · 2025 $2,099

Food & beverage: $2,099
CompanyPaymentsAmount
ABBVIE INC.19$362
Takeda Pharmaceuticals U.S.A., Inc.14$283
Madrigal Pharmaceuticals7$256
Janssen Biotech, Inc.11$218
Ardelyx, Inc.9$212
Lilly USA, LLC9$185
Celltrion USA Inc.7$141
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$115
Regeneron Healthcare Solutions, Inc.4$107
Ipsen Biopharmaceuticals, Inc3$72

Products named: ENTYVIO, REZDIFFRA, TREMFYA, IBSRELA, RINVOQ, OMVOH, VEGZELMA, DUPIXENT.

Industry payments across TX — which companies pay providers there.